Non-Hodgkin's Lymphoma Survival Rate by Stage

This article looks at the Non-Hodgkin lymphoma survival rate. Non-Hodgkin's lymphoma (NHL) is a very broad term for cancers affecting the lymphocytes in the body's immune system and varying the Non-Hodgkin lymphoma survival rate. The disease generally presents as painless, rubbery swollen lymph nodes in the neck, clavicle or groin, although lymphoma can originate virtually anywhere in the body—in lymph nodes or beyond them—because the lymphatic system, which carries lymphocytes, traverses the whole body.

According to statistics from the last forty years, lymphomas constitute one of the fastest-growing cancer categories in the United States, and they are among the handful of most frequently diagnosed cancers in the country. However, this may not be a true representation of the frequency of the disease since more and more subtypes of NHL are identified every year, which is almost without doubt leading to more diagnoses.

Incidence and Mortality of Non-Hodgkin's Lymphoma

Each year, approximately 65,500 people in the US will receive a diagnosis of non-Hodgkin's lymphoma, and over 20,000 people will succumb to the disease annually.

The median age at diagnosis for non-Hodgkin's lymphoma is 66. About two-thirds of all NHLs are diagnosed between the ages of 55 and 84, and there is a slightly higher incidence among men versus women. The median age at death for this broad cancer is 75; about one-third of all deaths from NHL occurs between the ages of 75 and 84.

Non-Hodgkin's Lymphoma Survival Rate by Stage

According to data published by the National Cancer Institute's Surveillance Epidemiology and End Results (SEER), one has reason to be optimistic about reviewing the Non-Hodgkin lymphoma survival rate. The Non-Hodgkin lymphoma survival rates expressed in terms of 5-year relative survival, meaning the percentage of people expected to be alive five years after initial diagnosis are quite impressive when set against many other cancers, and it is evident that early detection favors long-term survival:

  • Early-stage (I), localized disease: 81.1%
  • Early-stage (I, II), regional disease: 70.5%
  • Later-stage (III, IV), metastasized disease: 58.5%

These 5 year relative Non-Hodgkin lymphoma survival rate reflect one of medicine's few major victories in the fight against cancer, and the field of effective treatment options is growing every year.

Source: National Cancer Institute SEER Stat Fact Sheets: Non-Hodgkin's Lymphomas
Photo: [SOURCE]

More Articles

More Articles

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

When you consider that the adult human body has anywhere from 300 to 700 lymph nodes, the better question might not be where ARE they located, but...

This entry looks at a non-Hodgkin's lymphoma called true histiocytic lymphoma (THL), also referred to as diffuse histiocytic lymphoma, and...

Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Intravascular lymphoma is a subtype of 'Lymphoma', an umbrella term that loosely refers to several dozen...

While the average lifespan for hamsters is only about 2.5 years, and they are therefore less prone to long-term illnesses, it is possible for a...

Burkitt's lymphoma is an aggressive B-cell lymphoma that is common in children...

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

Lymphoma is a life-threatening disease, but is very treatable in most cases. The 5-year survival for patients diagnosed with non-Hodgkin's...

T cell lymphoma treatment options for these cancers are not especially effective and there is no absolute consensus about optimal treatments for...

Marginal zone lymphomas (MZL) are indolent lymphomas that affect the B-cells. The...

Lymphomas can arise from most any lymphatic tissue (lymph nodes, spleen, thymus, mucosa associated lymphoid...